Gynecomastia Procedures Market Size - By Procedure Type (Liposuction, Excision), By Age Group (18-40 Years, Above 40 Years), By End-use& Global Forecast to 2032

Gynecomastia Procedures Market Size

Gynecomastia Procedures Market size was valued at USD 808.5 million in 2022 and is estimated to account for USD 1.8 billion by 2032. Gynecomastia procedures are medical treatments aimed at addressing the enlargement of male breast tissue, known as gynecomastia.
 

This condition can occur due to hormonal imbalances, certain medications, or underlying medical issues and can affect males of all ages, causing physical discomfort and emotional distress. The procedures aim to reduce or eliminate excess breast tissue and restore a more masculine chest appearance. The choice of treatment depends on the severity of the condition, the patient's age, overall health, and cosmetic goals. Moreover, growing awareness, surge in technological advancements, rising social acceptance, and improved healthcare infrastructure.
 

Obesity is closely linked to hormonal imbalances, particularly an increase in estrogen levels relative to testosterone. Excess adipose tissue in obese individuals can lead to higher estrogen production, contributing to the development of gynecomastia. The fat tissues can be excised through liposuction, surgical excision, and other procedures including lasers, radiofrequency, or ultrasound. For instance, according to the 2022 report from the World Health Organization (WHO), more than 1 billion people worldwide are affected by obesity, and this number is still increasing. Furthermore, by 2025, around 167 million individuals will experience health issues due to obesity.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the gynecomastia procedures market initially, as many elective and non-urgent medical procedures, including cosmetic surgeries, were postponed, or cancelled due to lockdown and healthcare system strain. The uncertainty and fear surrounding the virus caused people to prioritize essential healthcare needs over elective treatments. Increasing awareness about gynecomastia and its treatment options, along with technological advancements, contributed to the recovery.
 

Gynecomastia Procedures Market Trends

Gynecomastia is often caused by hormonal imbalances, where the ratio of estrogen to testosterone is disrupted. This hormonal shift can occur due to numerous factors, including aging, certain medications, medical conditions, and lifestyle choices. For instance, according to statistics from the National Institutes of Health (NIH), around 50% to 60% of adolescent males experience gynecomastia. In younger individuals, gynecomastia symptoms are typically linked to higher-than-normal estrogen levels in the body. Additionally, approximately 65% of men between the ages of 27 and 92 years’ experience some degree of gynecomastia.
 

Consequently, there is a growing need for gynecomastia procedures to alleviate the physical and emotional impact of the condition. Furthermore, technological advancements in the medical field have significantly impacted gynecomastia treatment options. Innovative technologies, such as laser-assisted liposuction and minimally invasive procedures, have made gynecomastia treatments safer, more effective with reduced recovery time. These advancements have attracted more patients to seek treatment for gynecomastia, as they offer improved outcomes and less invasive procedures compared to traditional methods.
 

Gynecomastia Procedures Market Analysis

The gynecomastia procedures market by procedure type is categorized into liposuction and excision. The excision segment garnered USD 450.1 million revenue size in the year 2022. Excision surgical procedure involves the removal of excess glandular tissue and sometimes excess skin from the male breast area. It is particularly effective for severe cases of gynecomastia or in cases during which non-surgical treatments are insufficient. Furthermore, advancements in surgical techniques and technology have improved the safety and outcomes of excision procedures, making them a preferred choice for several patients and healthcare professionals.
 

Based on age group, the gynecomastia procedures market is segmented into 18-40 years and above 40 years. The above 40 years segment garnered USD 497.7 million revenue size in the year 2022. Gynecomastia becomes more prevalent with age due to hormonal changes. Older individuals are prompted to seek medical intervention as they have lived with the condition for a longer time, and its emotional impact increases over time. Additionally, with increased awareness and disposable income, this age group is more inclined to invest in cosmetic procedures for improved appearance and quality of life. Furthermore, advancements in medical technology and surgical techniques have also made gynecomastia procedures safer and more appealing to this demographic, driving the demand for treatments among individuals above 40 years old.
 

Based on end-use, the gynecomastia procedures market is segmented into hospitals, cosmetic surgical centers, and others. The cosmetic surgical centers segment garnered 62% market size in the year 2022. Cosmetic surgical centers specialize in aesthetic procedures and have skilled plastic surgeons experienced in gynecomastia treatments. Offering a range of surgical and non-surgical options caters to diverse patient needs, and their focus on patient comfort and safety builds trust. Furthermore, active marketing efforts, including digital platforms and social media, increase their visibility.
 

U.S. gynecomastia procedures market accounted for USD 305.4 million revenue size in 2022. The U.S. dominates the gynecomastia procedures regional analysis due to its well-established healthcare infrastructure, advanced medical facilities, and a large number of qualified plastic surgeons, offering a wide range of treatment options. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) 2021 survey report, the U.S. has conducted the highest number of aesthetic procedures globally, accounting for 24.1% of the total and among these, 30.4% were aesthetic non-surgical procedures, and 15.5% were aesthetic surgical procedures. Furthermore, the U.S. leads in technological advancements and medical research, attracting patients seeking the latest and most effective procedures.
 

Gynecomastia Procedures Market Share

Some of the eminent industry participants operating in the gynecomastia procedures market include:

• MicroAire Surgical Instruments
• Vyaire Medical
• Alma Lasers
• Bausch Health Companies
• Stryker Corporation
• Lumenis
• Aesthetic Group
• Candela Corporation
• Johnson & Johnson
• Cutera
• Merz Pharma
• GALDERMA
• Cynosure (Hologic, Inc.)
•  AbbVie Inc.
   

Gynecomastia Procedures Industry News:

• In April 2021, several new technologies were introduced for treatment of gynecomastia including fat grafting, ultrasound-assisted liposuction (UAL), among others. Such innovative technologies have enabled the expansion of tissue removal capability by liposuction.
   

Gynecomastia procedures market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Procedure Type (USD Million & Volume)

• Liposuction
• Excision

By Age Group (USD Million)

• 18-40 years
• Above 40 years

By End-use (USD Million)

• Hospitals
• Cosmetic surgical centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey